Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
JP Morgan announcing their significant holding in hVIVO plc:
https://polaris.brighterir.com/public/hvivo/news/rns/story/rn4g70x
Read the RNS...
...or listen to the CEO
this facility is more for headroom. An ICON facility. Saves OCTP issuing an expensive prospectus (Maybe £200-300k)
https://total-market-solutions.com/2024/01/oxford-cannabinoid-technologies-holdings-plc-jan-2024/
This Cornerstone signals a powerful endorsement of the progress Oxford Cannabinoid Technologies is making
“…Our mission is to unlock the therapeutic potential of cannabinoids and we are some way down that path…”
Whole article plus interview : https://total-market-solutions.com/2024/01/oxford-cannabinoid-technologies-holdings-plc-jan-2024/
Interview Only : https://youtu.be/hFZGXkKnM_g
Calling @HVIVO +10% pre market. New 52 week high today possibly…
“…Small ahead of market expectations. Business remains highly cash generative and intends to commence payments of an annual dividend…”
https://polaris.brighterir.com/public/hvivo/news/rns/story/xopzn1r
Some key points here:
-BOD plan new share purchases
-Funded for 2024
-Disko main focus
-Selling Finnish assets to get additional cash in the bank
-Greenland/Danish governments still supportive shareholders
Full article :
https://total-market-solutions.com/2024/01/bluejay-mining-plc-jan-2024/
Interview Only :https://youtu.be/i_9UOExW7Wc
Https://www.poolbegpharma.com/investors/events-presentations/
Could the Empire Pitfield Titanium Project really be the biggest thing on the planet?
“…I am super excited. Forty holes drilled. Nearly six thousand meters of drilling. EVERY hole drilled from surface to the end hit titanium mineral. It’s an extraordinary outcome…”
Interview only ;
https://youtu.be/URl1TaELp24
Interview plus article :
https://total-market-solutions.com/2024/01/empire-metals-ltd-jan-2024/
Tough questions for VAST with measured, tenacious and very confident answers in reply. (Link below)
“…How dependent are the Companies finances on the Diamonds? Do they even exist? What other options do the Company have? Is there any game changing news due?…”
Interview link :
https://youtu.be/u_WV6H4nK8w
Article plus interview link :
https://total-market-solutions.com/2024/01/vast-resources-plc-jan-2024/
Learn more about this morning's announcement by tuning into @InvestorMeetCo with some of the #POLB team & guest speaker, Dr Martin Kaiser from The Institute of Cancer Research & The Royal Marsden Hospital.
https://www.investormeetcompany.com/poolbeg-pharma-plc/register-investor
-Company getting funds in and have (selling) assets with $1m
-Company just raised £600k
-G&A costs covered for next 12 months
-NOBODY at the Company getting paid (except accountants etc etc)
-Vast area
-ULTRA high grade samples (read todays RNS below)
https://www.londonstockexchange.com/news-article/ECR/review-of-lolworth-project/16282450
Just the Interview with CEO Lorna Blaisse, link below...
https://youtu.be/soNLk0jANwo
Full article plus interview, then click below :
https://total-market-solutions.com/2024/01/helium-one-global-ltd-5/
“…Whatever course the market takes, PXEN seems better positioned than it has for some time, with a reliable income stream from two onshore assets, permit applications underway to drill five wells in Spain and three wells in Italy, and closure of its debt issues…”
https://total-market-solutions.com/2024/01/prospex-energy-plc-4/
“…Once mining permits have been secured, which the company says are imminent, plant and equipment currently in use at Marsfontein will move to the larger prospect. BOD continues to offer one of the few opportunities to invest in junior diamond exploration. The company may be a bold bet for 2024 if it can resume drilling and find interest from possible venture partners…”
https://total-market-solutions.com/2024/01/botswana-diamonds-plc/
HVIVO has had a quick kick off to 2024 with a new £6.3m human rhinovirus (HRV – the common cold virus) human challenge contract with a biotechnology client to test its antiviral candidate. The study is expected to commence in H2 2024, with revenue recognised in 2024 and 2025.
The human challenge trials can provide quick efficacy data which has the potential to significantly enhance the value of their clients’ assets, something which is critical in the current tight biotech investment landscape.
There is renewed focus and capital available to biopharma companies with assets targeting respiratory disease indications and their HRV Human Challenge Model offers our clients the opportunity to open up these markets, given HRV’s association to exacerbation of asthma and COPD.
https://www.londonstockexchange.com/news-article/HVO/ps6-3m-hrv-contract-signed-with-biotech-client/16270884
...one could point out that the company has ALREADY announced in April this year that the Prime Minister and the Minister had both assured the company they would support the extension of the license, and the company would be obliged to correct that if it were no longer the case.
The company has explained why both it and the government wish to connect the license extension documentation to the time actually required to complete the NJOM-3 work in process, so there is no reason to expect a problem here.
Https://total-market-solutions.com/2023/12/20-mining-companies-for-2024-part-ii-g-z/
Https://total-market-solutions.com/2023/12/20-mining-companies-for-2024-part-ii-g-z/
Https://total-market-solutions.com/2023/12/20-mining-companies-for-2024-part-ii-g-z/